Scientists at the University of Oxford in the U.K. have launched first-in-human vaccine trials for the deadly Nipah virus which impacts many Asian countries, including India.
(For top health news of the day, subscribe to our newsletter Health Matters)
The trials of the ChAdOx1 NipahB vaccine, consisting of 51 people aged 18 to 55, will be led by the Oxford Vaccine Group.